Ansun Biopharma's Seed VC - III Round

Ansun Biopharma raised a round of funding on May 23, 2014. Investors include OrbiMed Advisors.

Ansun Biopharma, formerly Nexbio, is a clinical stage biopharmaceutical company focused on the development of unique host-directed anti-viral therapies for respiratory viruses. …

Articles about Ansun Biopharma's Seed VC - III Round: